TSC2 and acute myeloid leukemia: As shown in Table 1, patients with TSC2 mutations had a significantly larger average AML largest diameter compared with patient populations with non-TSC2 mutations (16.37 ± 9.61 cm vs 9.14 ± 6.84 cm, P = 0.042).